Advagene Biopharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	18.18	52.82	65.19	18.01	14.33	121.89
Short-Term Investments	149.5	149.5	60	85	209.5	130
Trading Asset Securities	-	-	-	-	-	21.6
Cash & Short-Term Investments	167.68	202.32	125.19	103.01	223.83	273.49
Cash Growth	73.70%	61.61%	21.54%	-53.98%	-18.16%	14.91%
Other Receivables	22.49	21.96	20.27	19.2	16.59	18.71
Receivables	22.49	21.96	20.27	19.2	16.59	18.71
Prepaid Expenses	0.66	0.54	0.95	3.61	3.57	1.94
Total Current Assets	190.83	224.82	146.41	125.82	244	294.14
Property, Plant & Equipment	5.93	6.89	1.04	3.22	5.41	7.91
Other Intangible Assets	-	-	-	9.81	9.02	13.73
Other Long-Term Assets	0.5	0.5	0.48	1.98	1.98	0.48
Total Assets	197.26	232.21	147.93	140.84	260.41	316.26
Accounts Payable	1.66	0.75	0.87	0.56	0.56	0.56
Accrued Expenses	3.97	4.7	5.99	6.05	5.79	10.16
Current Portion of Leases	0.4	1.26	-	1.35	1.27	1.23
Other Current Liabilities	0.17	0.4	1.11	0.46	0.65	0.58
Total Current Liabilities	6.19	7.11	7.97	8.42	8.27	12.53
Long-Term Leases	3.61	4.56	-	0.65	2.57	4.4
Total Liabilities	9.8	11.67	7.97	9.08	10.84	16.93
Common Stock	593.8	593.8	533.8	493.49	492.92	445.42
Additional Paid-In Capital	-	90	60.39	3.12	95.12	5.06
Retained Earnings	-406.35	-463.26	-454.22	-364.85	-338.47	-247.73
Comprehensive Income & Other	-	-	-	-	-	96.57
Shareholders' Equity	187.46	220.54	139.96	131.76	249.57	299.33
Total Liabilities & Equity	197.26	232.21	147.93	140.84	260.41	316.26
Total Debt	4.01	5.82	-	2.01	3.84	5.63
Net Cash (Debt)	163.68	196.5	125.19	101	220	267.87
Net Cash Growth	80.44%	56.96%	23.95%	-54.09%	-17.87%	12.54%
Net Cash Per Share	2.84	3.60	2.48	2.05	4.51	6.04
Filing Date Shares Outstanding	59.38	59.38	53.38	49.35	49.29	44.54
Total Common Shares Outstanding	59.38	59.38	53.38	49.35	49.29	44.54
Working Capital	184.64	217.72	138.44	117.39	235.72	281.61
Book Value Per Share	3.16	3.71	2.62	2.67	5.06	6.72
Tangible Book Value	187.46	220.54	139.96	121.95	240.55	285.6
Tangible Book Value Per Share	3.16	3.71	2.62	2.47	4.88	6.41
Machinery	1.34	1.21	1.36	1.4	3.09	5.27
Leasehold Improvements	-	-	-	-	-	2.4

Source: S&P Global Market Intelligence. Standard template. Financial Sources.